what-can-we-expect-in-china-in-2019
Overseas CXO/ life science upstream 2Q24 review: life science upstream continuing to expect demand recovery
–Expecting upbeat margin on better ARM
Expect an unexciting set of results in 1Q24E, potential recovery in 2H24E
ESOP targets stabilize earnings expectation but sentiment overhang remains
–1H23E Preview： strong growth despite industry headwinds; expect back-loaded in 2H23E
–Expecting a sequential recovery in 4Q
Expect a profit turnaround in 2023E
PMI beat expectations as economy continues to recover
Can Fiscal Consolidation Announcements Help Anchor Inflation Expectations?
公众号
小程序
社群
公众号小程序社群